Drugs for Myelomeningocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 28)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Oxybutynin |
Approved, Investigational |
Phase 4 |
|
5633-20-5 |
4634 |
Synonyms:
1508-65-2 (hydrochloride)
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl a-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolate ester
4-(diethylamino)-2-Butynyl α-phenylcyclohexaneglycolic acid ester
4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-Butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate
4-(diethylamino)-2-Butynyl-alpha-phenylcyclohexaneglycolate
4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate
4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate
4-diethylamino-2-Butinyl a-cyclohexylmandelat
4-diethylamino-2-Butinyl alpha-cyclohexylmandelat
4-Diethylamino-2-butinyl alpha-cyclohexylmandelat
4-diethylamino-2-Butinyl α-cyclohexylmandelat
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolate
4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl alpha-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl a-phenylcyclohexaneglycolic acid
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolate
4-diethylamino-2-Butynyl α-phenylcyclohexaneglycolic acid
5633-20-5
AC1L1ILV
AC-2153
apo-Oxybutynin
Benzeneacetate, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetate, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, a-cyclohexyl-a-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester
Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butynyl ester
BPBio1_000214
BRD-A65013509-003-03-8
BSPBio_000194
C07360
CCRIS 1923
CHEBI:7856
CHEMBL1231
CID4634
Contimin
Cyclohexaneglycolate, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolate, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, a-phenyl-, 4-(diethylamino)-2-butynyl ester
Cyclohexaneglycolic acid, α-phenyl-, 4-(diethylamino)-2-butynyl ester
Cystonorm
Cystrin
D00465
DB01062
Ditropan
Ditropan, Lyrinel XL, Oxytrol, Oxybutynin
Dresplan
Dridase
Driptane
FT-0082890
Gelnique
|
Gen-oxybutynin
HSDB 3270
I06-2117
L000923
Lopac0_000923
LS-28714
MolPort-003-849-741
NCGC00015767-06
NCGC00089795-02
novo-Oxybutynin
Nu-oxybutyn
Oxibutinina
Oxibutinina [INN-Spanish]
Oxibutyninum
Oxyb abz
Oxybugamma
Oxybutin holsten
Oxybutinin
Oxybuton
oxybutynin
Oxybutynin
Oxybutynin (USAN/INN)
Oxybutynin [USAN:INN:BAN]
Oxybutynin al
Oxybutynin azu
Oxybutynin base
Oxybutynin Base
Oxybutynin chloride
Oxybutynin heumann
Oxybutynin hexal
Oxybutynin hydrochloride
Oxybutynin stada
oxybutynin topical gel
Oxybutynin topical gel
Oxybutynin von CT
Oxybutynine
Oxybutynine [INN-French]
Oxybutynin-puren
Oxybutynin-ratiopharm
Oxybutyninum
Oxybutyninum [INN-Latin]
Oxymedin
Oxytrol
Oxytrol (TN)
PMS-Oxybutynin
Pollakisu
Prestwick0_000287
Prestwick1_000287
Prestwick2_000287
Prestwick3_000287
Renamel
Ryol
S1754_Selleck
Spasmex oxybutynin
Spasyt
SPBio_002413
Tavor
transdermal patch
Transdermal patch
UNII-K9P6MC7092
Zatur
|
|
2 |
|
Darifenacin |
Approved, Investigational |
Phase 2 |
|
133099-04-4 |
444031 |
Synonyms:
(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-a,a-diphenyl-3-pyrrolidineacetamide
(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide
(S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide
(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-α,α-diphenyl-3-pyrrolidineacetamide
(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-α,α-diphenyl-3-pyrrolidineacetamide
133099-04-4
2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide
2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide
AC1L9FKY
AC-302
CHEBI:391960
CHEMBL1346
CID444031
D03654
darifenacin
Darifenacin
|
Darifenacin (USAN/INN)
Darifenacin hydrobromide
Darifenacin hydrochloride
Darifenacina
Darifenacine
Darifénacine
Darifenacinum
Darifenicin
DB00496
Emselex
Enablex
LS-187359
MolPort-005-943-011
NCGC00168775-01
STOCK6S-73577
|
|
3 |
|
Neurotransmitter Agents |
|
Phase 2 |
|
|
|
4 |
|
Cholinergic Agents |
|
Phase 2 |
|
|
|
5 |
|
Muscarinic Antagonists |
|
Phase 2 |
|
|
|
6 |
|
Cholinergic Antagonists |
|
Phase 2 |
|
|
|
7 |
|
Methenamine |
Approved, Vet_approved |
Phase 1 |
|
100-97-0 |
4101 |
Synonyms:
[16]-Adamazane, inn
1,3,5,7-Tetraazaadamantane
1,3,5,7-tetraazatricyclo (3.3.1.1(3,7))Decane
1,3,5,7-tetraazatricyclo(3.3.1.13,7)Decane
1,3,5,7-tetraazatricyclo(3.3.1.13,7)Decane hydroiodide
1,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]Decane
1,3,5,7-tetraazatricyclo[3.3.1.1~3,7~]decane
1,3,5,7-tetraazatricyclo[3.3.1.13,7 ]Decane
1,3,5,7-tetraazatricyclo[3.3.1.13,7]decane
aceto HMT
Aminoform
Aminoformaldehyde
Ammoform
Ammonioformaldehyde
Antihydral
Carin
Cystamin
Cystogen
Duirexol
e239
Ekagom H
Esametilentetramina
Formaldehyde-ammonia 6:4
Formamine
Formin
Formin (heterocycle)
Formin (the heterocyclic compound)
Grasselerator 102
H.m.t.
Herax uts
Heterin
HEX
Hexa
Hexa (vulcanization accelerator)
Hexa-flo-pulver
Hexaform
Hexaloids
Hexamethylamine
Hexamethylenamine
Hexamethylene tetramine
Hexamethyleneamine
Hexamethylenetetraamine
Hexamethylenetetramine
Hexamethylenetetramine (aliphatic)
Hexamethylenetetramine, 8ci
Hexamethylenetetramine, acs
Hexamethylenetetramine-palladium chloride adduct
Hexamethylenetetraminum
|
Hexamethylentetramin
Hexamethylentetramine
Hexamethylentetraminum
Hexamine
Hexamine (heterocycle)
Hexamine silver
Hexaminum
Hexasan
Hexilmethylenamine
HMT
HMTA
Mandelamine
metenamina
Metenamina
Methamin
Methenamin
Methenamine
méthénamine
Methenamine silver
Methenamine, silver
methenaminum
Methenaminum
Metramine
Naphthamine
Natasol fast orange GR salt
Nocceler H
Preparation af
Resotropin
S 4 (Heterocycle)
Sanceler H
Silver methenamine
Silver, hexamine
Silver, methenamine
Tetraazaadamantane
Uramin
Uratrine
Urisol
Uritone
Urodeine
uro-Phosphate
Urotropin
Urotropine
Vesaloin
Vesalvine
Vulkacit H 30
Vulkacit H30
Xametrin
|
|
8 |
|
Mycophenolic acid |
Approved |
Phase 1 |
|
24280-93-1 |
446541 |
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acid, mycophenolic
Acide mycophenolique
acido Micofenolico
Acido micofenolico
Acidum mycophenolicum
Melbex
|
micofenolico acido
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic acid
Mycophenolsaeure
Mycophenolsäure
Myfortic
|
|
9 |
|
Acidophilus |
|
Phase 1 |
|
|
|
10 |
|
Methenamine mandelate |
|
Phase 1 |
|
|
|
11 |
|
Methenamine hippurate |
|
Phase 1 |
|
|
|
12 |
|
Antitubercular Agents |
|
Phase 1 |
|
|
|
13 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
14 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
15 |
|
Antibiotics, Antitubercular |
|
Phase 1 |
|
|
|
16 |
|
Nitrous oxide |
Approved, Vet_approved |
|
|
10024-97-2 |
948 |
Synonyms:
00583_FLUKA
10024-97-2
126386-65-0
129451-49-6
130835-71-1
147527-07-9
175876-44-5
295590_ALDRICH
794457-85-5
847968-13-2
850203-00-8
AC1L1ADZ
C00887
CCRIS 1225
CHEBI:17045
CHEMBL1234579
CID948
D00102
D009609
Diazyne 1-oxide
Dinitrogen monoxide
Dinitrogen oxide
Distickstoffmonoxid
e942
EINECS 233-032-0
Factitious air
FEMA 2779
FEMA No. 2779
Gas, laughing
Gas, Laughing
gaz hilarant
Gaz hilarant
HSDB 504
Hyponitrous acid anhydride
Lachgas
Laughing gas
LS-7622
N2O
Nitral
Nitrious oxide
Nitrogen hypoxide
|
Nitrogen monoxide
Nitrogen oxide (N2O)
Nitrogen protoxide
nitrogenium oxydulatum
Nitrogenium oxydulatum
nitrous oxide
Nitrous oxide
Nitrous oxide (JP15/usp)
Nitrous oxide (JP15/USP)
Nitrous oxide (TN)
Nitrous oxide [Anaesthetics, volatile]
Nitrous oxide [JAN]
Nitrous oxide [UN1070] [Nonflammable gas]
Nitrous oxide [UN1070] [Nonflammable gas]
Nitrous oxide, compressed
Nitrous oxide, jan, usan
Nitrous oxide, refrigerated liquid
Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas]
Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas]
Nitrous-oxide
NITROUS-OXIDE
NNO
Oxide, nitrous
Oxide, Nitrous
oxido Nitroso
Oxido nitroso
óxido nitroso
Oxido nitroso [Spanish]
oxidodinitrogen(N--N)
Oxidodinitrogen(N--N)
oxyde nitreux
Oxyde nitreux
protoxyde d'azote
Protoxyde d'azote
Protoxyde d'azote [French]
R-744a
Stickdioxyd
Stickdioxyd [German]
Stickstoff(I)-oxid
UN1070
UN2201
|
|
17 |
|
Acetylcholine |
Approved, Investigational |
|
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
18 |
|
tannic acid |
Approved |
|
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
19 |
|
Benzocaine |
Approved, Investigational |
|
|
94-09-7, 1994-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
|
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
20 |
|
Imidacloprid |
Vet_approved |
|
|
105827-78-9 |
86418 |
Synonyms:
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine
(e)-Imidacloprid
(Z)-Imidacloprid
1-((6-chloro-3-Pyridinyl)methyl)-N-nitro-2-imidazolidinimine
1-((6-chloro-3-Pyridyl)methyl)-N-nitro-2-imidazolidinimine
1-(2-chloro-5-Pyridylmethyl)-2-(nitroimino)imidazolidine
1-[(6-chloro-3-Pyridinyl)methyl]-4,5-dihydro-N-nitro-1H-imidazol-2-amine, 9ci
Admire
Advantage
Advantage flea adulticide
Bayer brand OF imidacloprid
|
Confidor
Confidor 200 SL
Confidor SL
Gaucho
IMD
Imidacloprid (old RN)
Merit
Merit (insecticide)
Premise 75
Provado
|
|
21 |
|
abobotulinumtoxinA |
|
|
|
|
|
22 |
|
Botulinum Toxins |
|
|
|
|
|
23 |
|
Botulinum Toxins, Type A |
|
|
|
|
|
24 |
|
Cola |
|
|
|
|
|
25 |
|
Anesthetics |
|
|
|
|
|
26 |
|
Pharmaceutical Solutions |
|
|
|
|
|
27 |
|
Calamus |
|
|
|
|
|
28 |
|
glucocorticoids |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 51)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele |
Unknown status |
NCT00175123 |
Phase 4 |
Botulinum A toxin |
2 |
A 14-day, Open-label, Multicenter, Dose-escalating, Sequential Cohort Study to Evaluate Pharmacodynamics (Urodynamics) and Pharmacokinetics, Clinical Efficacy, Tolerability and Safety, Following Multiple Doses (mg/kg/Day) of Darifenacin Liquid Oral Suspension Given b.i.d. (Twice Daily) in Children, Ages 2 - 15 Years, With Neurogenic Detrusor Overactivity |
Terminated |
NCT00712322 |
Phase 2 |
Darifenacin;Darifenacin;Darifenacin;Darifenacin |
3 |
Bacteriuria Eradication Through Probiotics |
Unknown status |
NCT00717600 |
Phase 1 |
|
4 |
Pilot Study of Mycophenolate Mofetil in Congenital Uropathies |
Completed |
NCT00193635 |
Phase 1 |
mycophenolate mofetil |
5 |
Study to Compare 2 Minimally Invasive Fetal Neural Tube Defect Repair Techniques: Repair Using Durepair Patch vs. Repair Without Durepair Patch |
Recruiting |
NCT03794011 |
Phase 1 |
|
6 |
Minimally Invasive Fetal Neural Tube Defect Repair Study |
Active, not recruiting |
NCT02230072 |
Phase 1 |
|
7 |
Changes in the Cuff Pressure in Infants in the Absence of Nitrous Oxide |
Unknown status |
NCT03088761 |
|
|
8 |
Open Spina Bifida Fetoscopic Repair Project |
Unknown status |
NCT03562286 |
|
|
9 |
NSC Assistive Technology Research: Reciprocating Gait Orthoses for Paraplegia Patients |
Unknown status |
NCT02227407 |
|
|
10 |
In Vivo Comparison of Air Charged Catheters With Water Filled Catheters for Intravesical and Intrarectal Pressures Recording During Urodynamic Study |
Unknown status |
NCT02030340 |
|
|
11 |
Effectiveness of Prophylaxis of Urinary Tract Infections in Children With a Probiotic Containing Lactobacillus Rhamnosus PL1 and Lactobacillus Plantarum PM1, a Randomised Clinical Trial |
Unknown status |
NCT03462160 |
|
|
12 |
Daily Physical Activity in Children and Adolescents With Low Lumbar and Sacral Level Myelomeningocele |
Completed |
NCT04186338 |
|
|
13 |
Impact of Prenatal Correction of Spina Bifida Using Fetoscopy and the SAFER Technique on Long-term Neurodevelopment. |
Completed |
NCT04356703 |
|
|
14 |
Can Dynamic Ultrasonography Replace Urodynamics in the Follow-up of Patients With Myelomeningocele: A Prospective Concurrent Study |
Completed |
NCT03550898 |
|
|
15 |
Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele |
Completed |
NCT04187027 |
|
|
16 |
Myelomeningocele Repair Randomized Trial |
Completed |
NCT00060606 |
|
|
17 |
Risk Factors Associated With Spontaneous Preterm Delivery Status Post Open Fetal Myelomeningocele Repair |
Completed |
NCT03073382 |
|
|
18 |
Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions |
Completed |
NCT01208584 |
|
|
19 |
Reliability of the Melbourne Assessment |
Completed |
NCT02595411 |
|
|
20 |
Feasibility of a Home-based Interactive System for Upper Limb Therapy (YouGrabber) |
Completed |
NCT02368223 |
|
|
21 |
Retrospective Study With Botulinic Toxin in Neurogenic Detrusor Overactivity |
Completed |
NCT03042052 |
|
detrusor infection of Botulinum toxin |
22 |
An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience |
Completed |
NCT03544970 |
|
|
23 |
Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial |
Completed |
NCT02361450 |
|
|
24 |
A Three-year Behavioral Treatment of Obese Children: the Effect of Age on Change in BMI SDS and Dropout Rate |
Completed |
NCT01029964 |
|
|
25 |
New Protocol for Identification of Serious Bacterial Infection in Febrile Newborn |
Completed |
NCT03183531 |
|
|
26 |
In Utero Endoscopic Correction of Myelomeningocele: Laparotomy Versus Percutaneous - A Pilot Study |
Recruiting |
NCT03856034 |
|
|
27 |
Extended Criteria For Fetal Myelomeningocele Repair: A Pilot Study |
Recruiting |
NCT02664207 |
|
|
28 |
Sleep-disordered Breathing in Infants With Myelomeningocele |
Recruiting |
NCT04251806 |
|
|
29 |
Early Feasibility Study of Fetoscopic Myelomeningocele Repair Using a Cryopreserved Human Umbilical Cord Allograft (NEOX Cord 1K®) as a Meningeal Patch |
Recruiting |
NCT04243889 |
|
|
30 |
Prenatal Endoscopic Repair of Fetal Spina Bifida |
Recruiting |
NCT02390895 |
|
|
31 |
Long Term Assessment and Outcome of Adult Patients With Congenital Genitourinary Abnormalities. |
Recruiting |
NCT03061084 |
|
|
32 |
Fetal Endoscopic Surgery for Spina Bifida |
Recruiting |
NCT03315637 |
|
|
33 |
Epigenetic Alterations in Stress Regulation Genes Among Newborns After Fetal Surgery for Myelomeningocele Repair: An Exploratory Study |
Recruiting |
NCT04027374 |
|
|
34 |
Qualitative In-depth Interviews With Women and Their Partners Concerning the Acceptability of Fetal Surgery |
Recruiting |
NCT03788122 |
|
|
35 |
Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida |
Recruiting |
NCT03090633 |
|
|
36 |
In-Utero Endoscopic Correction of Spina Bifida: Laparotomy or Percutaneous |
Recruiting |
NCT04362592 |
|
|
37 |
Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Nocturnal Enuresis in Children |
Recruiting |
NCT04313192 |
|
|
38 |
Comparative Study in the Clinical Efficacy, Satisfaction and Complications While Treating Walking Spica Cast vs Synthetic Pants in the Management of Pediatric Low-energy Femoral Shaft Fracture. Randomized Clinical Trial |
Recruiting |
NCT04311866 |
|
|
39 |
Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children |
Recruiting |
NCT02900495 |
|
|
40 |
Prenatal Surgical Repair of Fetal Myelomeningocele |
Active, not recruiting |
NCT01983345 |
|
|
41 |
Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study |
Enrolling by invitation |
NCT03936322 |
|
|
42 |
Telemedicine in Spina Bifida Transition: A Pilot Study |
Enrolling by invitation |
NCT03466996 |
|
|
43 |
EVALUATION OF THE SENSORY-MOTOR RESPONSE IN PATIENTS WITH MYELOMENINGOCELE FOLLOWING TREATMENT WITH PHOTOBIOMODULATION |
Not yet recruiting |
NCT04035863 |
|
|
44 |
The Effects of Physical Therapy Associated With Photobiomodulation on Functional Performance in Children With Low Lumbar and Sacral Myelomeningocele - A Randomized, Blinded Clinical Trial. |
Not yet recruiting |
NCT04425330 |
|
|
45 |
A Patient-centered Approach to Urinary Incontinence and Quality of Life in Children and Adolescents With Spina Bifida |
Not yet recruiting |
NCT03410667 |
|
|
46 |
Case Control Study to Investigate the Use of Urethral Pressure Profile Measurement in Children |
Not yet recruiting |
NCT04147793 |
|
|
47 |
Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0 |
Terminated |
NCT02509377 |
|
|
48 |
Evaluation of Hysterotomy Site After Open Fetal Surgery |
Terminated |
NCT02493062 |
|
|
49 |
Open Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 And 40.0 |
Terminated |
NCT03044821 |
|
|
50 |
Prospective Randomized Controlled Trial Comparing Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer. |
Terminated |
NCT01751503 |
|
|
Cochrane evidence based reviews: meningomyelocele
|